Randomized controlled trial of medicine intervention for the adults’ Kashin-Beck disease in Kuasha village of Aba

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000038

Enrollment

Unknown

Registered

2014-09-21

Start date

2008-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Kashin-Beck disease

Interventions

Group A:Diclofenac sodium

Group B:Glucosamine hydrochloride

Group C:Diclofenac sodium + glucosamine hydrochloride

Group D:Placebo

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with diagnosis of various stages in the Kashin-Beck disease; aged between 18 and 65 years old, both males and females can be included; patients who are supposed to complete the observation of 1 year; patients who are willing to take part in and cooperate in the trial

Exclusion criteria

Exclusion criteria: 1. History of peptic ulcer; 2. Severe hepatic of renal dysfunction; 3. Recent gastrointestinal hemorrhage; 4. Severe coronary heart disease or heart dysfunction; 5. Pregnant or breast-feeding women.

Design outcomes

Primary

Measure	Time frame
Improvement of pain;Multiple indexe;	—

Secondary

Measure	Time frame
Pain scores, Rigidity scores, Physiologic function;Improvement of quality of life;Inflammation metabolism indicator;	—

Contacts

Public ContactLi Weimin, Dong Birong

birondong@hotmail.com+86 028 81812332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026